SCHEMBL6540304

SCHEMBL6540304

O=C(O)c1ccc(S(=O)(=O)c2ccc(CCN(Cc3ccccc3)C[C@H](O)c3cccc(Cl)c3)cc2)cc1F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB3 P13945 13/20 0.49
ADRB1 P08588 11/20 0.49
CXCR3 P49682 2/20 0.41
MEN1 O00255 1/20 0.39
POLB P06746 1/20 0.39
KMT2A Q03164 1/20 0.39
TAS2R14 Q9NYV8 1/20 0.39
CA12 O43570 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
CA4 P22748 1/20 0.38
PSEN1 P49768 1/20 0.37
PSEN2 P49810 1/20 0.37
SPPL2A Q8TCT8 1/20 0.37
APH1B Q8WW43 1/20 0.37
NCSTN Q92542 1/20 0.37
APH1A Q96BI3 1/20 0.37
PSENEN Q9NZ42 1/20 0.37
LMNA P02545 1/20 0.37
PKM P14618 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6540308 1.00 ADRB3 (0.49) ADRB3ADRB1CXCR3MEN1POLB
SCHEMBL6678776 0.91 ADRB3 (0.43) ADRB3ADRB1MEN1POLBKMT2A
SCHEMBL6678773 0.91 ADRB3 (0.43) ADRB3ADRB1MEN1POLBKMT2A
SCHEMBL6540172 0.91 ADRB1 (0.40) ADRB3ADRB1POLBCA12CA1
SCHEMBL6540179 0.91 ADRB1 (0.40) ADRB3ADRB1POLBCA12CA1
SCHEMBL6805795 0.87 ADRB3 (0.44) ADRB3ADRB1MEN1POLBKMT2A
SCHEMBL6805800 0.87 ADRB3 (0.44) ADRB3ADRB1MEN1POLBKMT2A
SCHEMBL6540568 0.86 OPRK1 (0.43) ADRB3ADRB1MEN1POLBKMT2A
SCHEMBL6540564 0.86 OPRK1 (0.43) ADRB3ADRB1MEN1POLBKMT2A
SCHEMBL6540670 0.86 OPRK1 (0.43) ADRB3ADRB1MEN1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040138462-A1 Aminoalcohol derivatives ASTELLAS PHARMA INC. (JP) 2004-07-15 US disclosed
EP-1389185-A2 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-02-18 EP disclosed
WO-2002094770-A2 AMINOALCOHOL DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-11-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040138462-A1 Aminoalcohol derivatives BPHL, FANCD2, HRH2 ADRB3 58/4885ADRB1 7/4885CXCR3 1320/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.